Journal Article
Clear cell chondrosarcoma in Von Hippel-Lindau disease
Koen M. A. Dreijerink; Rachel S. van Leeuwaarde; Wenzel M. Hackeng; Rachel H. Giles; Wendy W. J. de Leng; Paul C. Jutte; Albert J. H. Suurmeijer; Bernadette P. M. van Nesselrooij; Lodewijk A. A. Brosens
Familial Cancer · Vol. 19, Issue 1 · pp. 41-45 · 2020
Abstract
A diagnosis of clear cell chondrosarcoma of the ulna was made in a patient with Von Hippel-Lindau disease (VHL). After surgery, genetic analysis of the tumor tissue showed loss of heterozygosity at the VHL gene locus. Immunohistochemical analysis confirmed loss of expression of the VHL protein in the tumor cells. In addition, abundant Cyclin D1 expression in the tumor was observed. Chondrosarcoma has been described before in a VHL patient and VHL protein expression has been correlated to tumor grade in a series of sporadic chondrosarcomas. In this report, we show that clear cell chondrosarcoma may be a rare but canonical VHL manifestation through a cell-autonomous mechanism involving somatic loss-of-heterozygosity of the VHL tumor suppressor gene. We discuss the relevance of this observation with regard to the pathogenesis of clear cell chondrosarcoma in the context of VHL.